Monashee Scales Back Structure: GPCR Bet Reassessed
A major hedge fund slashed its stake in Structure Therapeutics, prompting questions about the future path for GPCR-fo...
Explore the best credit cards for bonus points and learn how to maximize your rewards. Start earning more today!
10,090 articlesA major hedge fund slashed its stake in Structure Therapeutics, prompting questions about the future path for GPCR-fo...
A claim of six primary wins is fueling talk of a pro-crypto mandate. This article breaks down what that signal could ...
In a hypothetical SpaceX IPO in 2026, Meta’s Mark Zuckerberg could emerge as the biggest winner, driven by AI investm...
A new wave of headlines around Nebius stock is stirring debate among investors. This guide breaks down what the news ...
A dramatic one-day move put Relay Therapeutics in the spotlight. After encouraging Phase 2 results for zovegalisib an...
The race to own the GLP-1 weight loss market has a new challenger in Viking Therapeutics. This article breaks down wh...
A high-profile venture capital tie-up is stirring markets as a rising firm expands rapidly. Reports say Donald Trump ...
Walmart recently released its latest quarterly results, but the stock moved on macro concerns as much as fundamentals...
As Walmart gears up for 2027, investors need a clear view of how groceries, online sales, and international markets s...
A Chinese AI lab is expanding from powering coding assistants to owning the entire toolchain. This move could reshape...
Today’s energy-focused market action shows how volatile solar stocks can be when short-seller whispers collide with b...
When Nvidia posts a blowout quarter, investors often wonder if the stock remains a smart buy. This article weighs his...